Paper65207
Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients.
Fujisawa T and 2 others. Cancer, 1977. Cited by 44 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Leukocyte adherence inhibition by soluble tumor antigens in breast cancer patients. Papers, record 65207. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/65207
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Breast Neoplasms | Major topic |
| Immunity, Cellular | Major topic |
| Immunologic Techniques | Major topic |
| Leukocyte Adherence Inhibition Test | Major topic |
| Adult | |
| Aged | |
| Antibodies, Neoplasm | |
| Antigens, Neoplasm | |
| Cell Adhesion | |
| Colonic Neoplasms | |
| Epitopes | |
| Female | |
| Humans | |
| Middle Aged | |
| Skin Tests |
Source PubMed
Cited by7
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31,182,982 | The role of interleukin-1 in general pathology. | Inflamm Regen | 2019 | https://conductscience.org/library/papers/31182982 | PubMed |
| 6,799,680 | Comparison of serum blocking factors on leucocyte adherence inhibition and PHA lymphocyte blastogenesis in breast cancer patients. | Jpn J Surg | 1981 | https://conductscience.org/library/papers/6799680 | PubMed |
| 6,606,065 | Transfer factor in restoration of cell mediated immunity in lung cancer patients. | Jpn J Surg | 1983 | https://conductscience.org/library/papers/6606065 | PubMed |
| 6,333,369 | Leucocyte adherence inhibition assay for cell-mediated immunity and immunodiagnosis of pancreatic cancer. | Gastroenterol Jpn | 1984 | https://conductscience.org/library/papers/6333369 | PubMed |
| 3,902,126 | Circulating anti-tumor and autoantibodies in breast carcinoma: relationship to stage and prognosis. | Breast Cancer Res Treat | 1985 | https://conductscience.org/library/papers/3902126 | PubMed |
| 369,585 | The natural history of antitumour immunity in human breast cancer assayed by tube leucocyte adherence inhibition. | Br J Cancer | 1978 | https://conductscience.org/library/papers/369585 | PubMed |
| 77,673 | Isolation of human tumour-specific antigens associated with beta2 microglobulin. | Br J Cancer | 1978 | https://conductscience.org/library/papers/77673 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| HLA-A | 3,105 | PubTator's text mining | https://conductscience.org/library/genes/3105 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/65207
GET https://conductscience.org/api/papers/v1/65207/authors